A Feasibility, Interventional, Prospective Study to Enhance Features and Optimise the Clinical Pathway for the TICI Research System in Adult Cochlear Implant Recipients

Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

This clinical study will test a new investigational totally implanted cochlear implant system (TICI G2). The cochlear implant has an implantable microphone under the skin to detect speech and sound from the environment allowing hearing without the need of any external parts. This study will explore new ways to process the sound from the implanted microphone. The study will be conducted in adults with sensorineural hearing loss, a type of hearing loss caused by damage to the inner ear or auditory nerve. The study participants will undergo a series of tests that include testing their implant and their hearing. They will also complete questionnaires to see how they rate their hearing and overall general health.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Aged 18 years or older, at time of consent

• Candidate for cochlear implantation as assessed by the implanting clinic

• Fluent in English, as determined by the investigator

• Willing to participate in and comply with all requirements of the protocol

• Willing and able to provide written informed consent

Locations
Other Locations
Australia
Royal Victoria Eye and Ear Hospital
RECRUITING
Melbourne
Contact Information
Primary
Niva Shrestha Clinical Project Manager
nshrestha@cochlear.com
+61 2 9428 6555
Time Frame
Start Date: 2024-11-18
Estimated Completion Date: 2027-11
Participants
Target number of participants: 12
Treatments
Experimental: Device :TICI G2 Clinical Investigation System
Totally implantable cochlear Implant
Related Therapeutic Areas
Sponsors
Leads: Cochlear

This content was sourced from clinicaltrials.gov

Similar Clinical Trials